Key facts
- This page summarizes David D. Allison's Form 4 filing for IPI Legacy Liquidation Co.
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 09 Apr 2024, 16:17.
David D. Allison - 05 Apr 2024 Form 4 Insider Report for IPI Legacy Liquidation Co
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 05 Apr 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Apr 2024, 16:17:28 UTC
- Prior SEC filing
- 20 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ David D. Allison
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David D. Allison filed Form 4 for IPI Legacy Liquidation Co on 09 Apr 2024.
Change
- Previous filing in this sequence was filed on 20 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IMPLQ
transaction
Derivative
Stock Option (right to buy)
Other
- Transaction value
- $0
- Shares
- -11,500
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,500
- Exercise price
- $9.96
- Footnotes
- F1, F2
IMPLQ
transaction
Derivative
Stock Option (right to buy)
Other
- Transaction value
- $0
- Shares
- -12,789
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,789
- Exercise price
- $8.65
- Footnotes
- F1, F2
IMPLQ
transaction
Derivative
Stock Option (right to buy)
Other
- Transaction value
- $0
- Shares
- -13,222
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,222
- Exercise price
- $1.34
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
David D. Allison is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Pursuant to the First Amended Joint Plan of Liquidation of Impel Pharmaceuticals Inc., which was confirmed by the United States Bankruptcy Court for the Northern District of Texas on April 2, 2024, all of the Issuer's shares of its capital stock were canceled and extinguished effective April 5, 2024, and any rights of any holder in respect thereof were canceled without any recovery.
Footnote F2
The option was fully vested.
Footnote F3
The option was scheduled to vest in full as of June 16, 2024.